Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Santosh Kumar Mandal"'
Autor:
AKKAS ALI, SHARIFUL ISLAM, SANTOSH KUMAR MANDAL, JULIA NASRIN, MAHBUBUR RAHMAN, RUHUL H. KUDDUS, SHAMSUL H. PRODHAN
Publikováno v:
Journal of BioScience and Biotechnology, Vol 3, Iss 1, Pp 15-22 (2014)
The aim of this study was to determine genetic diversity and relationships among the salt-tolerant rice landraces cultivated in the coastal districts of Bangladesh. DNA extracted from seedlings of nine salt-tolerant local rice landraces and three est
Externí odkaz:
https://doaj.org/article/e071a4cc449941e9a21fb635f81ebe25
Autor:
Santosh Kumar Mandal, S G Gupta
Publikováno v:
Journal of Nepal Medical Association, Vol 48, Iss 176 (2009)
Abstract
Externí odkaz:
https://doaj.org/article/be89198b74f444b083a82d44c957ee7f
Autor:
Pamela Christudoss, Debashish Danda, Maya Pavalasseril Ganesan, Gowri Mahasampath, Ramya Janardana, Pulukool Sandhya, P. Chebbi, Jayakanthan Kabeerdoss, Roy Arulraj, Santosh Kumar Mandal
Publikováno v:
International Journal of Rheumatic Diseases. 25:61-69
Background B cells contribute significantly to the pathogenesis of primary Sjogren's syndrome (pSS). Free light chains (FLCs) are generated during the production of immunoglobulins (Igs) and are surrogates of B cell activity. We hypothesized that sal
Autor:
Pradip Kumar Sarma, Sukumar Mukherjee, R N Sarkar, Santosh Kumar Mandal, Pradeepta Patra, Tanoy Bose, Ajit Surin, Santa Naorem, Kaushik Basu, J.R. Parida, CT Arunachalam
Publikováno v:
International Journal of Medical Research and Review; Vol 10 No 4 (2022): Jul-Aug; 113-121
Introduction: Owing to dearth of data on infliximab biosimilars in Indian patients, a pan-India case database-based study with infliximab biosimilar BOW015 (Infimab™) was carried out to capture its efficacy and safety in real world clinical setting
Autor:
Janardana Ramya, Santosh Kumar Mandal, Jayakanthan Kabeerdoss, Pulukool Sandhya, Debashish Danda, Gowri Mahasampath
Publikováno v:
Rheumatology International. 38:831-836
Human and animal model studies suggest CXCL13 is a potential biomarker in primary Sjogren’s syndrome (pSS). CXCL13 has not been studied in Indian patients with pSS. pSS cases classified by American European Consensus Group (AECG) or American colleg
Autor:
Nikhil Gupta, Prakash Ramasamy, Aswin Nair, Santosh Kumar Mandal, Debashish Danda, Arvind Ganpati, Ashish J. Mathew, Ruchika Goel, John Mathew
Publikováno v:
Clinical Rheumatology. 36:2273-2279
Mycophenolate mofetil (MMF) is an effective therapeutic agent with high safety profile in the management of lupus nephritis. This retrospective study was conducted to assess the efficacy and side effect profile of MMF as induction as well as maintena
Autor:
Debashish Danda, Ramya Aithala, Pulukool Sandhya, Jayakanthan Kabeerdoss, Gowri Mahasampath, Pamela Christudoss, Victoria Job, Santosh Kumar Mandal
Publikováno v:
International Journal of Rheumatic Diseases. 20:760-766
Objective To estimate levels of salivary and serum free light chains (FLCs) and explore its utility as a biomarker in primary Sjogren's syndrome (pSS). Methods Patients with pSS classified by American European Consensus group 2002 or American College
Publikováno v:
Journal of Evolution of Medical and Dental Sciences. 5:4666-4672
Autor:
Suvrat Arya, Shyamkumar Nindugala Keshava, Arvind Ganapati, Aswin Nair, Debashish Danda, Ruchika Goel, Ashish J. Mathew, Santosh Kumar Mandal, Nikhil Gupta, George Joseph
Publikováno v:
Indian Journal of Rheumatology. 10:S30-S42
Publikováno v:
Journal of Heuristics. 21:359-390
The mixed capacitated general routing problem (MCGRP) is concerned with the determination of the optimal vehicle routes to service a set of customers located at nodes and along edges or arcs on a mixed weighted graph representing a complete transport